Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement
Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the ut...
Ausführliche Beschreibung
Autor*in: |
---|
Format: |
E-Artikel |
---|
Erschienen: |
Walter de Gruyter ; 2011 |
---|
Schlagwörter: |
---|
Umfang: |
7 |
---|
Reproduktion: |
Walter de Gruyter Online Zeitschriften |
---|---|
Übergeordnetes Werk: |
Enthalten in: Clinical chemistry and laboratory medicine - Berlin [u.a.] : De Gruyter, 1998, 50(2011), 3 vom: 5. Dez., Seite 463-469 |
Übergeordnetes Werk: |
volume:50 ; year:2011 ; number:3 ; day:5 ; month:12 ; pages:463-469 ; extent:7 |
Links: |
---|
DOI / URN: |
10.1515/cclm.2011.809 |
---|
Katalog-ID: |
NLEJ246737093 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLEJ246737093 | ||
003 | DE-627 | ||
005 | 20230506145615.0 | ||
007 | cr uuu---uuuuu | ||
008 | 220814s2011 xx |||||o 00| ||und c | ||
024 | 7 | |a 10.1515/cclm.2011.809 |2 doi | |
028 | 5 | 2 | |a artikel_Grundlieferung.pp |
035 | |a (DE-627)NLEJ246737093 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
245 | 1 | 0 | |a Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement |
264 | 1 | |b Walter de Gruyter |c 2011 | |
300 | |a 7 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
520 | |a Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. | ||
533 | |f Walter de Gruyter Online Zeitschriften | ||
650 | 4 | |a clinical laboratories | |
650 | 4 | |a total testing process | |
650 | 4 | |a turnaround time, quality in laboratory medicine | |
650 | 4 | |a quality indicators | |
650 | 4 | |a quality specifications | |
700 | 1 | |a Sciacovelli, Laura |4 oth | |
700 | 1 | |a Sonntag, Oswald |4 oth | |
700 | 1 | |a Padoan, Andrea |4 oth | |
700 | 1 | |a Zambon, Carlo Federico |4 oth | |
700 | 1 | |a Carraro, Paolo |4 oth | |
700 | 1 | |a Plebani, Mario |4 oth | |
773 | 0 | 8 | |i Enthalten in |t Clinical chemistry and laboratory medicine |d Berlin [u.a.] : De Gruyter, 1998 |g 50(2011), 3 vom: 5. Dez., Seite 463-469 |w (DE-627)NLEJ248235222 |w (DE-600)1492732-9 |x 1437-4331 |7 nnns |
773 | 1 | 8 | |g volume:50 |g year:2011 |g number:3 |g day:5 |g month:12 |g pages:463-469 |g extent:7 |
856 | 4 | 0 | |u https://doi.org/10.1515/cclm.2011.809 |z Deutschlandweit zugänglich |
912 | |a GBV_USEFLAG_U | ||
912 | |a ZDB-1-DGR | ||
912 | |a GBV_NL_ARTICLE | ||
951 | |a AR | ||
952 | |d 50 |j 2011 |e 3 |b 5 |c 12 |h 463-469 |g 7 |
matchkey_str |
article:14374331:2011----::oioigultidctrilbrtrmdcndentuoaialr |
---|---|
hierarchy_sort_str |
2011 |
publishDate |
2011 |
allfields |
10.1515/cclm.2011.809 doi artikel_Grundlieferung.pp (DE-627)NLEJ246737093 DE-627 ger DE-627 rakwb Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement Walter de Gruyter 2011 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. Walter de Gruyter Online Zeitschriften clinical laboratories total testing process turnaround time, quality in laboratory medicine quality indicators quality specifications Sciacovelli, Laura oth Sonntag, Oswald oth Padoan, Andrea oth Zambon, Carlo Federico oth Carraro, Paolo oth Plebani, Mario oth Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 50(2011), 3 vom: 5. Dez., Seite 463-469 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:50 year:2011 number:3 day:5 month:12 pages:463-469 extent:7 https://doi.org/10.1515/cclm.2011.809 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 50 2011 3 5 12 463-469 7 |
spelling |
10.1515/cclm.2011.809 doi artikel_Grundlieferung.pp (DE-627)NLEJ246737093 DE-627 ger DE-627 rakwb Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement Walter de Gruyter 2011 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. Walter de Gruyter Online Zeitschriften clinical laboratories total testing process turnaround time, quality in laboratory medicine quality indicators quality specifications Sciacovelli, Laura oth Sonntag, Oswald oth Padoan, Andrea oth Zambon, Carlo Federico oth Carraro, Paolo oth Plebani, Mario oth Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 50(2011), 3 vom: 5. Dez., Seite 463-469 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:50 year:2011 number:3 day:5 month:12 pages:463-469 extent:7 https://doi.org/10.1515/cclm.2011.809 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 50 2011 3 5 12 463-469 7 |
allfields_unstemmed |
10.1515/cclm.2011.809 doi artikel_Grundlieferung.pp (DE-627)NLEJ246737093 DE-627 ger DE-627 rakwb Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement Walter de Gruyter 2011 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. Walter de Gruyter Online Zeitschriften clinical laboratories total testing process turnaround time, quality in laboratory medicine quality indicators quality specifications Sciacovelli, Laura oth Sonntag, Oswald oth Padoan, Andrea oth Zambon, Carlo Federico oth Carraro, Paolo oth Plebani, Mario oth Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 50(2011), 3 vom: 5. Dez., Seite 463-469 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:50 year:2011 number:3 day:5 month:12 pages:463-469 extent:7 https://doi.org/10.1515/cclm.2011.809 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 50 2011 3 5 12 463-469 7 |
allfieldsGer |
10.1515/cclm.2011.809 doi artikel_Grundlieferung.pp (DE-627)NLEJ246737093 DE-627 ger DE-627 rakwb Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement Walter de Gruyter 2011 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. Walter de Gruyter Online Zeitschriften clinical laboratories total testing process turnaround time, quality in laboratory medicine quality indicators quality specifications Sciacovelli, Laura oth Sonntag, Oswald oth Padoan, Andrea oth Zambon, Carlo Federico oth Carraro, Paolo oth Plebani, Mario oth Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 50(2011), 3 vom: 5. Dez., Seite 463-469 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:50 year:2011 number:3 day:5 month:12 pages:463-469 extent:7 https://doi.org/10.1515/cclm.2011.809 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 50 2011 3 5 12 463-469 7 |
allfieldsSound |
10.1515/cclm.2011.809 doi artikel_Grundlieferung.pp (DE-627)NLEJ246737093 DE-627 ger DE-627 rakwb Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement Walter de Gruyter 2011 7 Text txt rdacontent Computermedien c rdamedia Online-Ressource cr rdacarrier Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. Walter de Gruyter Online Zeitschriften clinical laboratories total testing process turnaround time, quality in laboratory medicine quality indicators quality specifications Sciacovelli, Laura oth Sonntag, Oswald oth Padoan, Andrea oth Zambon, Carlo Federico oth Carraro, Paolo oth Plebani, Mario oth Enthalten in Clinical chemistry and laboratory medicine Berlin [u.a.] : De Gruyter, 1998 50(2011), 3 vom: 5. Dez., Seite 463-469 (DE-627)NLEJ248235222 (DE-600)1492732-9 1437-4331 nnns volume:50 year:2011 number:3 day:5 month:12 pages:463-469 extent:7 https://doi.org/10.1515/cclm.2011.809 Deutschlandweit zugänglich GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE AR 50 2011 3 5 12 463-469 7 |
source |
Enthalten in Clinical chemistry and laboratory medicine 50(2011), 3 vom: 5. Dez., Seite 463-469 volume:50 year:2011 number:3 day:5 month:12 pages:463-469 extent:7 |
sourceStr |
Enthalten in Clinical chemistry and laboratory medicine 50(2011), 3 vom: 5. Dez., Seite 463-469 volume:50 year:2011 number:3 day:5 month:12 pages:463-469 extent:7 |
format_phy_str_mv |
Article |
institution |
findex.gbv.de |
topic_facet |
clinical laboratories total testing process turnaround time, quality in laboratory medicine quality indicators quality specifications |
isfreeaccess_bool |
false |
container_title |
Clinical chemistry and laboratory medicine |
authorswithroles_txt_mv |
Sciacovelli, Laura @@oth@@ Sonntag, Oswald @@oth@@ Padoan, Andrea @@oth@@ Zambon, Carlo Federico @@oth@@ Carraro, Paolo @@oth@@ Plebani, Mario @@oth@@ |
publishDateDaySort_date |
2011-12-05T00:00:00Z |
hierarchy_top_id |
NLEJ248235222 |
id |
NLEJ246737093 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ246737093</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506145615.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2011 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/cclm.2011.809</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ246737093</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Walter de Gruyter</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">clinical laboratories</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">total testing process</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">turnaround time, quality in laboratory medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">quality indicators</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">quality specifications</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sciacovelli, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sonntag, Oswald</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Padoan, Andrea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zambon, Carlo Federico</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carraro, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Plebani, Mario</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Clinical chemistry and laboratory medicine</subfield><subfield code="d">Berlin [u.a.] : De Gruyter, 1998</subfield><subfield code="g">50(2011), 3 vom: 5. Dez., Seite 463-469</subfield><subfield code="w">(DE-627)NLEJ248235222</subfield><subfield code="w">(DE-600)1492732-9</subfield><subfield code="x">1437-4331</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:50</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:3</subfield><subfield code="g">day:5</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:463-469</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/cclm.2011.809</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">50</subfield><subfield code="j">2011</subfield><subfield code="e">3</subfield><subfield code="b">5</subfield><subfield code="c">12</subfield><subfield code="h">463-469</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
series2 |
Walter de Gruyter Online Zeitschriften |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)NLEJ248235222 |
format |
electronic Article |
delete_txt_mv |
keep |
collection |
NL |
remote_str |
true |
illustrated |
Not Illustrated |
issn |
1437-4331 |
topic_title |
Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement clinical laboratories total testing process turnaround time, quality in laboratory medicine quality indicators quality specifications |
publisher |
Walter de Gruyter |
publisherStr |
Walter de Gruyter |
topic |
misc clinical laboratories misc total testing process misc turnaround time, quality in laboratory medicine misc quality indicators misc quality specifications |
spellingShingle |
misc clinical laboratories misc total testing process misc turnaround time, quality in laboratory medicine misc quality indicators misc quality specifications Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement |
topic_unstemmed |
misc clinical laboratories misc total testing process misc turnaround time, quality in laboratory medicine misc quality indicators misc quality specifications |
topic_browse |
misc clinical laboratories misc total testing process misc turnaround time, quality in laboratory medicine misc quality indicators misc quality specifications |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
cr |
author2_variant |
l s ls o s os a p ap c f z cf cfz p c pc m p mp |
hierarchy_parent_title |
Clinical chemistry and laboratory medicine |
hierarchy_parent_id |
NLEJ248235222 |
hierarchy_top_title |
Clinical chemistry and laboratory medicine |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)NLEJ248235222 (DE-600)1492732-9 |
title |
Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement |
ctrlnum |
(DE-627)NLEJ246737093 |
title_full |
Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement |
journal |
Clinical chemistry and laboratory medicine |
journalStr |
Clinical chemistry and laboratory medicine |
isOA_bool |
false |
recordtype |
marc |
publishDateSort |
2011 |
contenttype_str_mv |
txt |
container_start_page |
463 |
container_volume |
50 |
physical |
7 |
format_se |
Elektronische Aufsätze |
doi_str_mv |
10.1515/cclm.2011.809 |
title_sort |
monitoring quality indicators in laboratory medicine does not automatically result in quality improvement |
title_auth |
Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement |
abstract |
Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. |
abstractGer |
Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. |
abstract_unstemmed |
Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams. |
collection_details |
GBV_USEFLAG_U ZDB-1-DGR GBV_NL_ARTICLE |
container_issue |
3 |
title_short |
Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement |
url |
https://doi.org/10.1515/cclm.2011.809 |
remote_bool |
true |
author2 |
Sciacovelli, Laura Sonntag, Oswald Padoan, Andrea Zambon, Carlo Federico Carraro, Paolo Plebani, Mario |
author2Str |
Sciacovelli, Laura Sonntag, Oswald Padoan, Andrea Zambon, Carlo Federico Carraro, Paolo Plebani, Mario |
ppnlink |
NLEJ248235222 |
mediatype_str_mv |
c |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth oth |
doi_str |
10.1515/cclm.2011.809 |
up_date |
2024-07-06T09:14:12.750Z |
_version_ |
1803820469062729728 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">NLEJ246737093</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230506145615.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">220814s2011 xx |||||o 00| ||und c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1515/cclm.2011.809</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">artikel_Grundlieferung.pp</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)NLEJ246737093</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Monitoring quality indicators in laboratory medicine does not automatically result in quality improvement</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="b">Walter de Gruyter</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">7</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">Text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">Computermedien</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">Online-Ressource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Background: Data on quality indicators (QIs) should be collected over time in order to identify and continuously monitor clinical laboratory performance and to improve patient safety by identifying and implementing effective interventions. The aim of the present study was to ascertain whether the utilization of a set of quality indicators over a 3-year period resulted in an improvement in the efficiency and effectiveness of an individual laboratory. Methods: Over a 3-year time interval (2009–2011), a series of 38 QIs covering all stages of the total testing process (21 in the pre-analytic, nine in the analytic and eight in the post-analytic phase) was monitored. Results: On the basis of their patterns, QIs have been grouped into the following categories: [1] seven QIs of the pre-analytical phase and three of the intra-analytical phase with a significant trend and a significant linearity demonstrating an improvement over time; [2] 10 QIs of the pre-analytical and two of the intra-analytical phase with a significant trend and a non-significant linearity demonstrating that changes were not constant; [3] two QIs of the pre-analytical and one of the intra-analytical phase with a non-significant trend and significant linearity showing neither improvement nor worsening; and [4] two QIs of the pre-analytical and three of the intra-analytical phase with a non-significant trend and non-significant linearity. Conclusions: Data on a set of QIs collected over a 3-year time-frame demonstrate that processes and indicators under the control of the clinical laboratory had improved much more than processes requiring close co-operation between the laboratory and care teams.</subfield></datafield><datafield tag="533" ind1=" " ind2=" "><subfield code="f">Walter de Gruyter Online Zeitschriften</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">clinical laboratories</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">total testing process</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">turnaround time, quality in laboratory medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">quality indicators</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">quality specifications</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sciacovelli, Laura</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sonntag, Oswald</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Padoan, Andrea</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Zambon, Carlo Federico</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Carraro, Paolo</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Plebani, Mario</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="t">Clinical chemistry and laboratory medicine</subfield><subfield code="d">Berlin [u.a.] : De Gruyter, 1998</subfield><subfield code="g">50(2011), 3 vom: 5. Dez., Seite 463-469</subfield><subfield code="w">(DE-627)NLEJ248235222</subfield><subfield code="w">(DE-600)1492732-9</subfield><subfield code="x">1437-4331</subfield><subfield code="7">nnns</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:50</subfield><subfield code="g">year:2011</subfield><subfield code="g">number:3</subfield><subfield code="g">day:5</subfield><subfield code="g">month:12</subfield><subfield code="g">pages:463-469</subfield><subfield code="g">extent:7</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1515/cclm.2011.809</subfield><subfield code="z">Deutschlandweit zugänglich</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-1-DGR</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_NL_ARTICLE</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">50</subfield><subfield code="j">2011</subfield><subfield code="e">3</subfield><subfield code="b">5</subfield><subfield code="c">12</subfield><subfield code="h">463-469</subfield><subfield code="g">7</subfield></datafield></record></collection>
|
score |
7.399907 |